1. 2019
  2. Theranostics in immuno-oncology using nanobody derivatives

    Lecocq, Q., De Vlaeminck, Y., Hanssens, H., D'Huyvetter, M., Raes, G., Goyvaerts, C., Keyaerts, M., Devoogdt, N. & Breckpot, K., 14 Oct 2019, In : Theranostics. p. 7772-7791 thno.34941.

    Research output: Contribution to journalSpecial issueResearch

  3. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use

    Lecocq, Q., Zeven, K., De Vlaeminck, Y., Martens, S., Massa, S., Goyvaerts, C., Raes, G., Keyaerts, M., Breckpot, K. & Devoogdt, N., 29 Sep 2019, In : Biomolecules. 9, 10, 20 p., 548.

    Research output: Contribution to journalArticleResearchpeer-review

  4. Iodinated anti-HER2 sdAb effectively targets and treats HER2 positive brain lesions

    Puttemans, J., D'Huyvetter, M., Lahoutte, T. & Devoogdt, N., 5 Sep 2019.

    Research output: Unpublished contribution to conferencePosterResearch

  5. Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

    Seremet, T., Jansen, Y., Planken, S., Njimi, H., Delaunoy, M., El Housni, H., Awada, G., Schwarze, J. K., Keyaerts, M., Everaert, H., Lienard, D., Del Marmol, V., Heimann, P. & Neyns, B., 5 Sep 2019

    Research output: Other contributionResearch

  6. Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases

    Puttemans, J., Lahoutte, T., D'Huyvetter, M. & Devoogdt, N., 1 Aug 2019, In : Pharmaceutics. 11, 8, 23 p., 376.

    Research output: Contribution to journalScientific reviewResearchpeer-review

  7. Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior

    Dekempeneer, Y., Back, T., Aneheim, E., Jensen, H., Puttemans, J., Xavier, C., Keyaerts, M., Palm, S., Albertsson, P., Lahoutte, T., Caveliers, V., Lindegren, S. & D'Huyvetter, M., Aug 2019, In : Molecular Pharmaceutics. 16, 8, p. 3524-3533

    Research output: Contribution to journalArticleResearchpeer-review

  8. Ga-68 DOTATATE Uptake in Hemangioma Simulating Metastasis on PET Imaging: CT helps characterize bone hemangioma that could be wrongly interpreted as skeletal metastases on 68Ga DOTATATE PET imaging

    Vertenten, B., Goethals, L. & De Geeter, F., 28 Jun 2019, In : Journal of the Belgian Society of Radiology. 103, 1, 38.

    Research output: Contribution to journalArticleResearchpeer-review

  9. Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic Agent

    Broos, K., Lecocq, Q., Xavier, C., Bridoux, J., Nguyen, T., Corthals, J., Schoonooghe, S., Lion, E., Raes, G., Keyaerts, M., Devoogdt, N. & Breckpot, K., 21 Jun 2019, In : Cancers. 11, 6, 19 p., 872.

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...14 Next

ID: 36386770